PHARMACOGENETICS OF VINORELBINE IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Vinorelbine (Primary) ; Vinorelbine (Primary)
- Indications Mesothelioma
- Focus Pharmacodynamics; Pharmacogenomic
- 09 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 09 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Jul 2016 Planned End Date changed from 1 May 2014 to 1 Dec 2016.